PEDIATRIC SURGERY UPDATE Volume 53, 2019
PSU Volume 53 No 01 JULY 2019
TPN Peritoneal Extravasation
Umbilical venous catheters (UVC) in newborns provide intravascular
access for administration of intravenous fluids, parenteral nutrition
(TPN), drugs, transfusions and central venous monitoring especially for
management of low birth weight infants. Improper placement of umbilical
catheters is associated with complications that may lead to
morbidity and mortality. The tip of the umbilical venous catheter
should be positioned at the junction of the inferior vena cava and
right atrium just at or above the level of the diaphragm (T7 to T9).
Also, adequate blood return must ne obtained before use. A normal
positioned UVC between T7 and T9 can stay in use up to 14 days if
intravenous access is in need, otherwise is advised to discontinue the
UVC by day 10 and replace it with a percutaneously place intravenous
central catheter. Improper placement of UVC can lead to intraperitoneal
extravasation of TPN. This may also lead to vessel perforation or liver
capsule disruption due to hepatic necrosis. The complication of
intraperitoneal spillage has an insidious onset. The infant will
develop abdominal distension, tenderness associated with acute pain,
ascites, dehydration, hemoconcentration, characteristic induration of
the abdominal wall due to infiltration of the soft tissue and acute
renal failure from hypovolemia and hypertonicity of TPN. Abdominal
ultrasound will demonstrate ascites. Paracentesis if performed reveals
a cloudy fluid high in glucose, triglycerides and protein consistent
with TPN. The differential diagnosis is chylous ascites with high
chylomicrons and lymphocytes in a peripheral smear of fluid sample.
Intraperitoneal TPN extravasation has also been reported after
placement of femoral central a venous catheter. Management of TPN
peritoneal extravasation should consist of catheter removal,
paracentesis or peritoneal exploration to accomplished peritoneal
lavage of the offending fluid. Prognosis is usually good if not
associated with serious liver laceration with uncontrollable hemorrhage.
References:
1- Egyepong J, Jain A, Chow P, Godambe S: Parenteral nutrition--ascites
with acute renal failure as a complication from an umbilical venous
catheter in an extremely low birth weight infant. BMJ Case Rep. 2011
Apr 26;2011. pii: bcr0220113813. doi:10.1136/bcr.02.2011.3813.
2- Sztajnbok J, Troster EJ: Acute abdomen due to late retroperitoneal
extravasation from a femoral venous catheter in a newborn. Sao Paulo
Med J. 120(2):59-61, 2002
3- Adesanya O, Naqvi M: Term Neonate With Liver Laceration, Obstructive
Uropathy, and Ascites-Secondary to Extravasation of Total Parenteral
Nutrition: A Complication of Malpositioned
Umbilical Venous Catheter. Glob Pediatr Health. 2016 Oct 12;3:2333794X16670494. eCollection 2016.
4- Shareena I, Khu YS, Cheah FC: Intraperitoneal extravasation of total
parental nutrition infusate from an umbilical venous catheter.
Singapore Med J. 49(2):e35-6, 2008
5- Guzoglu N, Erdeve O, Yilmaz Y, Dilmen U: Intraperitoneal
extravasation from umbilical venous catheter in differential diagnosis
of neonatal chylous ascites. Acta Paediatr. 99(9):1284, 2010
6- Selvam S, Humphrey T, Woodley H, English S, Kraft JK: Sonographic
features of umbilical catheter-related complications. Pediatr Radiol.
48(13):1964-1970, 2018
Alpha-1-Antitrypsin Deficiency
Alpha-1-antitrypsin is a glycoprotein produced primarily in the
liver secreted under the influence of proinflammatory cytokines forming
several globulins whose roles are to suppress additional tissue damage
by neutralizing granulocyte elastase and proteinase primarily in the
lung during infective and inflammatory process. Is responsible for
protecting tissues against proteolytic damage by enzymes like
neutrophil elastase and proteinase. It is also a tissue reparation
inductor. Deficiency of alpha-1-antitrypsin (A1ATD) is a rare autosomal
recessive co-dominant disorder most often seen in Northern European
ancestry populations. A1ATD is the most common genetic cause of
pediatric liver disease and transplantation. The defect in
alpha-1-antitrypsin expression in the hepatocyte is followed by damage
to the liver and/or lungs primarily. A1ATD can be asymptomatic or
long-lasting and even permanently symptomatic depending in expression
on the genotype and numerous exogenous factors such as infection, toxic
or other damages to the liver and lungs. Liver damage occurs due to
intrahepatocyte retention of alpha-1-antitrypsin and in the lung due to
the lack of its protective effect. Early in life A1ATD causes a
cholestatic syndrome, conjugated hyperbilirubinemia beyond the second
week of life, associated with low birth weight and poor weight gain
sometimes difficult to differentiate from biliary atresia. The liver
damage is severe in only 1-2% of affected patients, most often has a
slowly progressive character and juvenile cirrhosis develops in 15% of
cases. In other organs A1ATD can cause pulmonary emphysema (chronic
obstructive pulmonary disease), cytoplasmic anti-neutrophil cytoplasmic
vasculitis and inflammatory necrotizing panniculitis in the skin. A1ATD
individuals screened at birth who smoke develop COPD by age of 40
years. A1ATD is also associated with other diseases such as rheumatoid
arthritis, sinusitis, nasal polyps, inflammatory bowel disease, peptic
ulcer disease and diabetes. Management of A1ATD is limited. A diagnosis
of A1ATD may have important implications including testing of family
members, genetic counseling, smoking avoidance, avoidance of high risk
occupations and consideration of augmentation therapy.
References:
1- Radlovic N, Lekovic Z, Radlovic V, Simic D, Topic A, Ristic D, Ducic
S, Baletic A: Alpha-1-antitrypsin deficiency in children: clinical
characteristics and diagnosis. Srp Arh Celok Lek. 142(9-10):547-50, 2014
2- Greulich T, Nell C, Hohmann D, Grebe M, Janciauskiene S, Koczulla
AR, Vogelmeier CF: The prevalence of diagnosed alpha-1-antitrypsin
deficiency and its comorbidities: results from a large population-based
database. Eur Respir J. 2017 Jan 4;49(1). pii: 1600154. doi:
10.1183/13993003.00154-2016. Print 2017 Jan.
3- Aboussouan LS, Stoller JK: Detection of alpha-1 antitrypsin deficiency: a review. Respir Med. 103(3):335-41, 2009
4- Piitulainen E, Mostafavi B, Tanash HA: Health status and lung
function in the Swedish alpha 1-antitrypsin deficient cohort,
identified by neonatal screening, at the age of 37-40 years. Int J
Chron Obstruct Pulmon Dis. 12:495-500, 2017
5- Khan Z, Venkat VL, Soltys KA, Stolz DB, Ranganathan S: A Challenging
Case of Severe Infantile Cholestasis in Alpha-1 Antitrypsin Deficiency.
Pediatr Dev Pathol. 20(2):176-181, 2017
6- Fregonese L, Stolk J: Hereditary alpha-1-antitrypsin deficiency and
its clinical consequences. Orphanet J Rare Dis. 2008 Jun 19;3:16. doi:
10.1186/1750-1172-3-16.
Thromboelastography
Coagulation disorders can lead to intra- or postoperative bleeding
associated with increased morbidity and mortality. The transfusion of
blood products to correct coagulopathy disorders is guided by clinical
judgement, standard laboratory testing (PT, PTT, platelets, bleeding
time, etc.), and thromboelastography testing. Thromboelastography (TEG)
is a viscoelastic hemostatic assay, a functional test of clot formation
and degradation performed on whole blood, at a point of care (emergency
department, intensive care units or operating room) for clotting system
deficiency that analyzes each phase of the coagulation process. Blood
from a patient is mixed with citrate and placed in a cup of the TEG
machine connected to a computer. The cup oscillates and the coagulation
process occurs. This testing rapidly generates numeric and graphic
results that can lead to guided-directed intervention for correct of
coagulation disorders. Five variables are measured using
thromboelastography. They are: R (reaction time) quantify as the time
until measurable clot is formed, usually between five and 10 minutes.
Should the patient have a prolonged R time then management is with
fresh frozen plasma transfusion. K time - time since initial clot
formation until it has a 20 mm fixed strength, normally one to 3
minutes. An abnormal K-time means low fibrinogen levels and is managed
with cryoprecipitate. Alpha angle - is the speed of fibrin
accumulation, similarly affected by fibrinogen levels. Normal alpha
angle is 53-72 degrees. Again, an abnormal alpha angle is managed with
cryoprecipitate. Maximum amplitude (MA) - consist of the highest
vertical amplitude of the TEG tracing. MA reflects the strength of the
clot normally reaching 50-70 mm. A narrow maximum amplitude is managed
with platelets infusion. LY30 percentage - represent 30% decrease in
the amplitude of the TEG tracing thirty minutes after maximum amplitude
is obtained. It is a measure of fibrinolysis normally being zero and
8%. A higher than normal LY30 is indicative of a hypercoagulable state
and may be managed with antifibrinolytics such as aminocaproic acid.
TEG is superior to conventional coagulation testing in detecting early
trauma coagulopathy reducing mortality. TEG should be available in
trauma level I and II centers.
References:
1- Wasowicz M, Srinivas C, Meineri M, et al: Technical report: analysis
of citrated blood with thromboelastography: comparison with fresh blood
samples. Can J Anaesth 55(5): 284-9, 2008
2- Chan KL, Summerhayes RG, Ignjatovic V, et al: Reference values for
kaolin-activated thromboelastography in healthy children. Anesth Analg
105(6): 1610-3, 2007
3- Rusell RT, Maizlin II, Vogel AM. Viscoelastic monitoring in
pediatric trauma: a survey of pediatric trauma society memebers. J Surg
Res. 214: 216-20, 2017
4- Wikkelso¸ A(1), Wetterslev J, Moller AM, Afshari A:
Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor
haemostatic treatment versus usual care in adults or children with
bleeding. Cochrane Database Syst Rev. 2016 Aug 22;(8):CD007871.
doi:10.1002/14651858.CD007871.pub3.
5- Figueiredo S, Tantot A, Duranteau J: Targeting blood products
transfusion in trauma: what is the role of thromboelastography? Minerva
Anestesiol. 82(11):1214-1229, 2016
6- Nogami K: The utility of thromboelastography in inherited and acquired bleeding disorders. Br J Haematol. 174(4):503-14, 2016
PSU Volume 53 No 02 AUGUST 2019
Xanthogranulomas
Xanthogranulomas are rare benign nodules that usually arise
in the subcutaneous tissue. When they appear in early infancy or
childhood they are called juvenile xanthogranulomas (JXG).
Approximately 20% are present at birth and most arise in the first year
of life. The anatomic predilection of appearance of juvenile
xanthogranuloma in children occurs in the head and neck region, though
appearance on the trunk, extremities and extracutaneous locations has
also been reported. Skin lesions are self-limited and can vary in size;
they can be solitary or multiple. In the eye, particularly the uveal
tract, is the most frequent site of extracutaneous involvement. JXG are
composed of collections of histiocytes, foamy cells and Touton giant
cells. The diagnosis of JXG requires histologic analysis of a biopsy
specimen or the nodule itself. JXG is a benign cutaneous
fibrohistiocytic lesion with a type of granulomatous process.
Clinically the lesion is papulonodular with a tan to orange color and
several millimeters in size. Children with multiple skin lesions or
younger than two years of age are at a greater risk for ocular
involvement. Systemic JXG which involves the visceral organs is rare
occurring in less than 5% of cases. Systemic JXG can appear in the
lung, heart, gastrointestinal tract, CNS, adrenal gland, pituitary
gland, bones or kidney. There is a sex male predilection for JXG.
Spontaneous regression of the cutaneous lesion is frequent.
Differential diagnosis includes spitz nevi, mastocytomas, and
dermatofibromas. Should the cutaneous nodule keep growing or cause
functional impairment it should be removed surgically. Removal must be
complete to avoid recurrence of the lesion. JXG generally carries a
good prognosis. Congenital giant JXG is a rare subtype most
commonly affecting newborn females.
References:
1- Pajaziti L, Hapaiu SR, Pajaziti A: Juvenile xanthogranuloma: a case
report and review of the literature. BMC Res Notes. 7:174, 2014
2- Logue ME(1), Elwood H, Smidt A: Congenital juvenile xanthogranuloma
with ulceration: a pediatric case report. Dermatol Online J. 23(7), 2017
3- Paxton CN, O'Malley DP, Bellizzi AM, et al: Genetic evaluation
of juvenile xanthogranuloma: genomic abnormalities are uncommon in
solitary lesions, advanced cases may show more complexity. Mod Pathol.
30(9):1234-1240, 2017
4- Mitra S, Gupta S, Menon P, Rao KL, Bal A: Juvenile Xanthogranuloma:
Presenting as an Isolated Renal Involvement. Fetal Pediatr Pathol.
35(6):420-424, 2016
5- Zahir ST, Sharahjin NS, Vahedian H, Akhavan A: Juvenile
xanthogranuloma presenting as a large neck mass and ocular
complications: a diagnostic and therapeutic dilemma. BMJ Case Rep. 2014
Apr 15;2014
6- Berti S, Coronella G, Galeone M, Balestri R, Patrizi A, Neri I:
Giant congenital juvenile xanthogranuloma. Arch Dis Child. 98(4):317,
2013
Cinematic Rendering
Detailed surgical anatomy provided by today imaging
technology is essential in planning preoperative surgical decisions,
surgical approach and ultimate management of many conditions. Virtual 3
dimensional (3-D) reconstruction techniques have been developed to help
surgeons have a more detailed situation of the anatomy of the disease.
Two types of 3-D rendering techniques are commonly utilized to
visualize volumetric 3-D data: surface shade display and volume
rendering. These techniques provide a global overview of volumetric
data along with detailed anatomical and pathological information which
is usually more difficult to discern in conventional 2-D images. In
2016 a new technique of 3-D visualization of cross sectional image data
called cinematic rendering (CR) was developed. Cinematic rendering is a
physically based volume-rendering method that works with random
sampling computational algorithms. Multiple light maps and transfer
function are used to generate a realistic depiction of medical imaging
data. This computer animation program was first used by the
entertainment industry. Data is retrieved from either conventional CT
and MRI scans to produce the cinematic rendering images. CR helps to
transfer complex surgical anatomical information to physicians. CR
visualization improves the correctness of image interpretation.
Moreover, CR enables the display of CT image data in a colored fashion.
Also, a 3-D printed anatomical model can be reconstructed before the
surgical procedure enabling the surgeon to study the precise anatomic
relationship of the tumor with its vascular supply, an integral part of
a surgical resection. Resident surgeons benefit more than attending
surgeons when using CR imaging as it enhances anatomic education. CR
imaging speeds up and improves the understanding of complex anatomical
situations compared with conventional CT Scanning in the chest, abdomen
and pelvis.
References:
1- Elshafei M, Binder J, Baecker J, et al: Comparison of Cinematic
Rendering and Computed Tomography for Speed and Comprehension of
Surgical Anatomy. JAMA Surg. Doi:10.1001/jamasurg.2019.1168
2- Yang J, Li K, Deng H, Feng J, Fei Y, Jin Y, Liao C, Li Q: CT
cinematic rendering for pelvic primary tumor photorealistic
visualization. Quant Imaging Med Surg. 8(8):804-818, 2018
3- Rowe SP, Johnson PT, Fishman EK: Initial experience with cinematic
rendering for chest cardiovascular imaging. Br J Radiol. 2018
Feb;91(1082):20170558. doi: 10.1259/bjr.20170558. Epub 2017 Oct 27.
4- Dappa E, Higashigaito K, Fornaro J, Leschka S, Wildermuth S, Alkadhi
H: Cinematic rendering - an alternative to volume rendering for 3D
computed tomography imaging. Insights Imaging. 7(6):849-856, 2016
5- Eid M, De Cecco CN, Nance JW Jr, et al: Cinematic Rendering in CT: A
Novel, Lifelike 3D Visualization Technique. AJR Am J Roentgenol.
209(2):370-379, 2017
6- Chu LC, Johnson PT, Fishman EK: Cinematic rendering of pancreatic
neoplasms: preliminary observations and opportunities. Abdom Radiol
(NY). 43(11):3009-3015, 2018
ERAS
Enhanced recovery after anesthesia (ERAS) is a recently
developed program of standardization of perioperative care driven by
clinical pathways impacting both surgical outcomes and efficiency of
care in high-volume centers. ERAS pathways have been shown to reduce
length of stay, reduce complication rates, reduce providers
communication errors and improve patient satisfaction in some adults
surgical procedures such as colorectal surgery. Few studies have
investigated the applicability of this paradigm to pediatric
populations. The ERAS society initially developed in Europe organized
the protocol into three contexts of care, namely preoperative,
intraoperative and postoperative. This include a multidisciplinary team
approach encompassing patient education, increased preop volume
loading, optimize nutrition, appropriated antibiotic prophylaxis,
short-acting anesthetics, maintenance of normothermia, minimally
invasive surgical techniques, avoiding drains, using epidural for chest
procedures, minimizing opioids analgesics, limiting intra- and postop
fluid resuscitation, early removal of drains and catheters, prevention
of nausea and vomiting, early oral nutrition, early postop mobility and
reporting outcomes. ERAS programs in adults have reduced length of stay
by one to two days without increasing readmission rates, decrease
postop complications by 30% and shortened return of bowel function by
one day. ERAS protocols offer an easy way to improve the cost of care.
ERAS protocol applied to the appropriate pediatric surgical populations
may be associated with decreased length of stay, decreased narcotic
use, and no detectable increase in complications. Pediatric studies
using ERAS have demonstrated less intervention than the 20 components
suggested for adults. These few pediatric studies have demonstrated
that ERAS implementation reduces length of stay by one day with no
increase in complications or readmissions, less use of IV fluid in the
operating room, less narcotic during hospitalization with early
tolerance of feedings. Shorter stay becomes a patient safety benefit as
errors and nosocomial infections are reduced upon early discharge. ERAS
protocol is well accepted by patients and families. Recent poll
demonstrated that pediatric surgeons are already executing several
individual ERAS interventions outside of an official protocol.
References:
1- Shinnick JK, Short HL, Heiss KF, Santore MT, Blakely ML, Raval MV:
Enhancing recovery in pediatric surgery: a review of the literature. J
Surg Res. 202(1):165-76, 2016
2- Leeds IL, Boss EF, George JA, Strockbine V, Wick EC, Jelin EB:
Preparing enhanced recovery after surgery for implementation in
pediatric populations. J Pediatr Surg. 51(12):2126-2129, 2016
3- Pearson KL, Hall NJ: What is the role of enhanced recovery after surgery in children? A scoping
review. Pediatr Surg Int. 33(1):43-51, 2017
4- Short HL, Heiss KF, Burch K, Travers C, Edney J, Venable C, Raval
MV: Implementation of an enhanced recovery protocol in pediatric
colorectal surgery. J Pediatr Surg. 53(4):688-692, 2018
5- Short HL, Taylor N, Thakore M, Piper K, Baxter K, Heiss KF, Raval
MV: A survey of pediatric surgeons' practices with enhanced recovery
after children's surgery. J Pediatr Surg. 53(3):418-430, 2018
6- Rove KO, Edney JC, Brockel MA: Enhanced recovery after surgery in
children: Promising, evidence-based multidisciplinary care. Paediatr
Anaesth. 28(6):482-492, 2018
PSU Volume 53 NO 03 SEPTEMBER 2019
Aspergillus Appendicitis
Fungi in very rare situations, mostly immunosuppressed
children, can cause appendicitis. Aspergillus is a widespread
fungus identified in the environment and usually enter the human body
by airborne transmission colonizing the nasal cavities or fascial
sinuses. Isolated gastrointestinal aspergillosis arises from ingestion
of food contaminated with Aspergillus and colonization by Aspergillus
of gastrointestinal ulcers which arise from previous chemotherapy. The
diagnosis of isolated (primary) aspergillus appendicitis is very rare,
is delayed and associated with profound immunosuppression. This last
factor of immunosuppression causes the delay in the clinical features
of appendicitis. The very few cases have demonstrated a clinical pentad
associated with this disease, namely: clinically-suspected
appendicitis, profound neutropenia, recent chemotherapy, acute leukemia
(either AML or ALL), and poor clinical course if managed solely with
antibiotics or anti-candida medication. Aspergillus fumigatus is the
most common and frequent species that causes infection in humans
followed by A. Flavus and A. terreus. As mentioned, ingested
contaminated food or mucosal ulcers from chemotherapy give rise to
Aspergillus infestation. Aspergillus invade the appendicial mucosal
wall due to immunosuppression from neutropenia and acute leukemia. The
child develops persistent right quadrant pain, fever and systemic GI
signs unresponsive to antibacterial or anti-candidal therapy.
Ultrasound or with greater accuracy a CT-Scan will show appendicitis.
The appendix should be removed promptly and the specimen
microscopically examined for Aspergillus with special stains.
Anti-Aspergillus therapy with voriconazole or amphotericin should be
instituted after removal of the appendix since the child will continue
to be colonized with the organism. Surgery is crucial for removing the
inflamed appendix, clearing the infection and producing tissue
sampling. Positive galactomannan levels guide the decision to change
the antifungal therapy regime.
References:
1- Gjeorgjievski M, Amin MB, Cappell MS: Characteristic clinical
features of Aspergillus appendicitis: Case report and literature
review. World J Gastroenterol. 21(44):12713-21, 2015
2- Decembrino N, Zecca M, Tortorano AM, Mangione F, Lallitto F,
Introzzi F, Bergami E, Marone P, Tamarozzi F, Cavanna C: Acute isolated
appendicitis due to Aspergillus carneus in a neutropenic child with
acute myeloid leukemia. New Microbiol. 39(1):65-9, 2016
3- Ozyurek E, Arda S, Ozkiraz S, Alioglu B, Arikan U, Ozbek N: Febrile
neutropenia as the presenting sign of appendicitis in an adolescent
with acute myelogenous leukemia. Pediatr Hematol Oncol. 23(3):269-73,
2006
4- Larbcharoensub N, Boonsakan P, Kanoksil W, Wattanatranon D,
Phongkitkarun S, Molagool S, Watcharananan SP: Fungal appendicitis: a
case series and review of the literature. Southeast Asian J Trop Med
Public Health. 44(4):681-9, 2013
5- Kim HS, Yeo HJ, Shin DH, Cho WH, Kim D: Isolated Acute Appendicitis
Caused by Aspergillus in a Patient Who Underwent Lung Transplantation:
A Case Report. Transplant Proc. 50(4):1199-1201, 2018
6- Ustun C: Laparoscopic appendectomy in a patient with acute
myelogenous leukemia with neutropenia. J Laparoendosc Adv Surg Tech A.
17(2):213-5, 2007
Eosinophilic Cellulitis
Eosinophilic cellulitis, also known as Well's syndrome, is a
rare inflammatory skin disorder of unknown etiology. Its
categorized as a relapsing eosinophilic dermatitis with variable
clinical appearance. Cutaneous lesions are variable in appearance and
may be similar to cellulitis, urticaria, insect bites, morphea or
contact dermatitis. During the acute phase the child develops tender
urticarial plaques, vesicles, bullae or nodules in the skin. This is
usually accompanied with peripheral blood eosinophilia. Papulovesicular
blistering and nodular lesions which are often painful or pruritic can
also be seen. Later the skin lesions become indurated with morphealike
appearance resolving without significant scarring. Histopathologic
findings of the lesion include eosinophilic granulomatous infiltration
of the dermis and formation of flame figures without signs of
vasculitis. Hypersensitivity due to different triggers such as insect
bites, or stings, drugs, infections, atopic dermatitis and contact
dermatitis have been proposed. Causative medications include
antibiotics, anticholinergic agents, anesthetics, non-steroidal
anti-inflammatory agents, thyroid medications, chemotherapeutic agents,
thiomersal containing vaccination, anti-tumor necrosis factor agents
and thiazide diuretics. Children with sensitivity to thiomersal found
in certain vaccines (such as influenza) can develop eosinophilic
cellulitis. Diagnosis of the condition might need biopsy for
histopathological identification. Other times the lesions coalesces and
cause a subcutaneous abscess which need to be drained. Well's syndrome
is initially managed successfully with topical or systemic
corticosteroids and calcineurin inhibitors but it often relapse upon
tapering. Systemic glucocorticosteroid are the most common and
effective treatment modality reported.
References:
1- Herout S, Bauer WM, Schuster C, Stingl G: Eosinophilic cellulitis
(Wells syndrome) successfully treated with mepolizumab. JAAD Case Rep.
4(6):548-550, 2018
2- Kucharczyk M, Slowik-Rylska M, Krecisz B: Insect bites as a trigger
factor of eosinophilic cellulitis. Ann Agric Environ Med.
26(2):256-259, 2019
3- Safran T, Masckauchan M, Maj J, Green L: Wells syndrome secondary to
influenza vaccination: A case report and review of the literature. Hum
Vaccin Immunother. 14(4):958-960, 2018
4- Yu AM, Ito S, Leibson T, Lavi S, Fu LW, Weinstein M, Skotnicki SM:
Pediatric Wells syndrome (eosinophilic cellulitis) after vaccination: A
case report and review of the literature. Pediatr Dermatol.
35(5):e262-e264, 2018
5- Ogueta I, Spertino J, Deza G, et al: Wells syndrome and chronic
spontaneous urticaria: report of four cases successfully treated with
omalizumab. J Eur Acad Dermatol Venereol. 2019 May 20. doi:
10.1111/jdv.15683. [Epub ahead of print].
6- Dabas G, De D, Handa S, Chatterjee D, Radotra BD: Wells syndrome in
a patient receiving adalimumab biosimilar: A case report and review of
literature. Indian J Dermatol Venereol Leprol. 84(5):594-599, 2018
Appendicitis in the Neutropenic Child
With advancement in chemotherapy many children now survived
to leukemia, lymphoma and other malignancies. The use of
chemotherapeutic agents is associated with bone marrow toxicity and
development of neutropenia along with infectious complications in the
gastrointestinal tract. Right quadrant pain in the neutropenic child
can be the direct consequence of acute appendicitis, neutropenic
typhlitis, pseudomembranous colitis or obstructive ileus. Both
appendicitis and neutropenic colitis are the most common surgical
complications in children with leukemia. The use of steroids in these
patients can masquerade acute appendicitis since the blunt the classic
signs of appendicitis such as abdominal tenderness, rebound tenderness,
involuntary guarding and abdominal wall rigidity. This causes confusion
in the clinician trying to determine of the child has an acute
abdominal condition or his symptoms are the result of side effects of
chemotherapy. The incidence of appendicitis in the population of
chemotherapy-induced neutropenia children is the same to the general
pediatric population (2% - 4%). The clinical presentation and findings
on physical exam of neutropenic children diagnosed with appendicitis
are often vague and atypical. Since the most important decision is to
differentiate acute appendicitis from neutropenic colitis children with
right lower abdominal pain, fever and CT Scan findings of cecal wall
thickness carries a presumptive diagnosis of typhlitis. In the absence
of these findings acute appendicitis should be suspected and managed
accordingly. Limited operative morbidity in neutropenic children with
appendicitis leads to favor surgery over medical antibiotic therapy
with delayed intervention. Medical management of appendicitis in the
child with neutropenia increase hospital stay and use of pain
medication. The majority of the children managed nonoperatively had
recurrence of their RLQ pain on subsequent rounds of chemotherapy.
Early appendectomy once the diagnosis is confirmed is safe and
eliminates the course of the disease in addition to avoiding the
concern for uncontrolled intraperitoneal contamination in the
immunosuppressed child.
References:
1- Hobson MJ, Carney DE, Molik KA, Vik T, Scherer LR 3rd, Rouse TM,
West KW, Grosfeld JL, Billmire DF: Appendicitis in childhood
hematologic malignancies: analysis and comparison with
typhilitis. J Pediatr Surg. 40(1):214-9, 2005
2- Mortellaro VE, Juang D, Fike FB, Saites CG, Potter DD Jr, Iqbal CW,
Snyder CL, St Peter S: Treatment of appendicitis in neutropenic
children. J Surg Res. 170(1):14-6, 2011
3- Tierney JS, Novotny NM: Appendectomy in neutropenic children: a safe
and expedient solution to a challenging problem. J Surg Res.
178(1):110-2, 2012
4- Scarpa AA, Hery G, Petit A, Brethon B, Jimenez I, Gandemer V, Abbou
S, Haouy S, Breaud J, Poiree M: Appendicitis in a Neutropenic Patient:
A Multicentric Retrospective Study. J Pediatr Hematol Oncol.
39(5):365-369, 2017
5- Ozyurek E, Arda S, Ozkiraz S, Alioglu B, Arikan U, Ozbek N: Febrile
neutropenia as the presenting sign of appendicitis in an adolescent
with acute myelogenous leukemia. Pediatr Hematol Oncol. 23(3):269-73,
2006
6- Angel CA, Rao BN, Wrenn E Jr, Lobe TE, Kumar AP: Acute appendicitis
in children with leukemia and other malignancies: still a diagnostic
dilemma. J Pediatr Surg. 27(4):476-9, 1992
PSU Volume 53 NO 04 OCTOBER 2019
Earlobes Keloids
Keloids and hypertrophied scars are benign
fibroproliferative cosmetic deformities of a wound original border
after injury or trauma. Keloids are the result of excessive collagen
deposition in genetically and/or environmental predisposed populations.
Almost 70% of keloids or hypertrophied scars occur in children. Keloids
occur in dark skin individuals (African American), are associated with
familiar history and related to hormonal changes caused by puberty. The
earlobe is the most common location for keloid development after injury
caused by piercing. Incidence of earlobe keloid development after ear
piercing is around 2.5%. During development and afterward keloids
causes pain, pruritus, tenderness, and cosmetic disfigurement impairing
the quality of life of the patient. The child with a keloid is affected
socially and psychologically. Earlobe keloids affect both genders
equally after ear piercing. The recurrence rate after simply excising
keloids is as high as 80%, the reason for using other adjuvant
therapies such as corticosteroid injection (Kenalog), cryotherapy,
cryosurgery, laser therapy and radiotherapy. The majority of these
treatment managements are associated with frequent recurrences. The
median time for recurrence after excision is six months, meaning that
long follow-up is needed to identify those cases that will eventually
recur. Intralesional corticosteroid placement is considered a main stay
of therapy of keloids owing to the ease of use and high degree of
endurance. Mechanisms of action of steroids include suppression of
inflammation, promotion of collagen degeneration and inhibition of
further collagen production. Side effects of intralesional steroid
therapy include cutaneous atrophy, skin hypopigmentation and pain
associated with the injection. Radiotherapy, though expensive, claims
local control after excision in more than 80% of patients. Radiation
reduces recurrence after excision by reducing cellular proliferation.
The preferred approach to pediatric earlobe keloids is excision with
closure using absorbable sutures and concomitant steroid
injection.
References:
1- Liu CL, Yuan ZY: Retrospective study of immediate postoperative
electron radiotherapy for therapy-resistant earlobe keloids. Arch
Dermatol Res. 311(6):469-475, 2019
2- Khan FA, Drucker NA, Larson SD, Taylor JA, Islam S: Pediatric
earlobe keloids: Outcomes and patterns of recurrence. J Pediatr Surg.
2019 Jul 24. pii: S0022-3468(19)30460-9.
doi:10.1016/j.jpedsurg.2019.07.006.
3- Hao YH, Xing XJ, Zhao ZG Xie F, Hao T, Yang Y, Li CX: A multimodal
therapeutic approach improves the clinical outcome of auricular keloid
patients. Int J Dermatol. 58(6):745-749, 2019
4- Aluko-Olokun B, Olaitan AA, Morgan RE, Adediran OM: Prevention of
Earlobe Keloid Recurrence After Excision: Assessment of the Value of
Presurgical Injection of Triamcinolone. J Craniofac Surg.
29(7):e673-e675, 2018
5- Prasad BRH, Leelavathy B, Aradhya SS, Shilpa K, Vasudevan B: Easing
the Excision of Earlobe Keloid. J Cutan Aesthet Surg. 10(3):168-171,
2017
6- Rodrigues FB, Bekerman C, Sousa J, Vieira J, Ramalhinho V: Bilateral
gigantic earlobe keloids. Clin Med (Lond). 16(1):91, 2016
CBD Dilatation After Cholecystectomy
With the current use of US for different intraabdominal
symptoms physician has found that common bile duct dilatation (CBD) can
occur after a cholecystectomy. Whether this finding is found in
patients who are asymptomatic or with symptoms it brings the difficult
situation if the dilatation found incidentally is pathological or not.
This brings further imaging studies to elucidate this controversy such
as MRCP or even ERCP in these patients. Studies that are either
expensive or invasive. It is believed this dilatation of the CBD in
post cholecystectomy patients is a physiologic response caused after
the reservoir ability of the gallbladder with its removal is lost.
Also, an increase in the intraluminal pressure of the CBD can be an
etiological factor. Many cross-sectional studies reveal that the CBD
diameter increases in gallbladder resected patients compared with
normal people. The dilatation of the CBD can be more than 6 mm observed
in 80% in the proximal part and 60% in the distal part of the CBD. This
dilatation after cholecystectomy seems to increase with the increase in
age of the patient. Eastern populations have shown that the CBD
dilatation is frequently accompanied by ampullary diverticulum, biliary
sludge or abnormal pancreatico-biliary anatomy. Most cases of CBD
dilatation after cholecystectomy are asymptomatic and have normal liver
function tests and total bilirubin. The patient sex, body weight and
height, diagnosis and bile duct diameters do not have an effect on the
postoperative common bile duct dilatation. A CBD dilatation within 10
mm in asymptomatic adult patients after cholecystectomy is permissible,
can be regarded as normal physiologic changes and does not warrant
further studies. This data has not been elucidated in
post-cholecystectomy children yet. In children the normal diameter of
the CBD depends on the age of the patient. Should the child present
with an asymptomatic dilatation of the CBD an MRCP should be performed.
References:
1- Majeed AW, Ross B, Johnson AG: The preoperatively normal bile duct
does not dilate after cholecystectomy: results of a five year study.
Gut. 45(5):741-3, 1999
2- Csendes G P, Csendes J A, Burgos L AM, Burdiles PP: [Bile duct
diameter before and 12 years after cholecystectomy]. Rev Med Chil.
135(6):735-42, 2007
3- Senturk S, Miroglu TC, Bilici A, Gumus H, Tekin RC, Ekici F, Tekbas
G: Diameters of the common bile duct in adults and postcholecystectomy
patients: a study with 64-slice CT. Eur J Radiol. 81(1):39-42, 2012
4- Park SM, Kim WS, Bae IH, Kim JH, Ryu DH, Jang LC, Choi JW: Common
bile duct dilatation after cholecystectomy: a one-year prospective
study. J Korean Surg Soc. 83(2):97-101, 2012
5- Benjaminov F, Leichtman G, Naftali T, Half EE, Konikoff FM: Effects
of age and cholecystectomy on common bile duct diameter as measured by
endoscopic ultrasonography. Surg Endosc. 27(1):303-7, 2013
6- Lindholm EB, Meckmongkol T, Feinberg AJ, et al: Standardization of
common bile duct size using ultrasound in pediatric patients. J Pediatr
Surg 54: 1123-1126, 2019
Urogenital Sinus
Urogenital sinus (UGS) refers to persistent anatomic defect
where there is a normally placed anus, but the bladder and vagina share
a common channel orifice. The vagina and urethra might join anywhere
along a spectrum from the bladder neck, with a common channel (high
confluence) to those that join near the perineum with a short common
UGS (low confluence). Urogenital sinus is a common feature of a variety
of congenital anomalies such as congenital adrenal hyperplasia (most
common), isolated malformation unrelated to masculinization or rectal
malformation and persistence of a cloacal malformation. The vast
majority of children with UGS abnormalities have genital ambiguity and
are thus identified as neonates. Hydrocolpus is relatively common and
affected infants may demonstrate other syndromic features. This
ambiguity is most commonly secondary to congenital adrenal hyperplasia
(CAH). The virilization of children with CAH cause clitoral enlargement
(clitoromegaly) and UGS. The larger the clitoris the longer the UGS
confluence. In order to provide management, the child with a UGS need
to undergo specific and detail imaging of the anatomy of the defect.
This includes pelvic US, MRI (including evaluation of spinal cord
anomalies), CT-Scan and VCUG. An endoscopy of the sinus tract is
imperative before embarking on repair. The goal of surgical correction
of the UGS is the creation of separate openings in the vulva for the
urethra and vagina with preservation of the function of both organs.
The relationship of the vagina to the bladder neck is the most critical
determining factor in the type of vaginoplasty to be performed. Using a
perineal approach either posterior vaginoplasty for short confluence
defects is utilized or partial/total urogenital mobilization for high
confluence defects is required to achieve such goals. Timing of surgery
is controversial. Cases with recurrent urinary tract infection and
significant Hydrocolpus should be reconstructed before the age of one
year. Complications include urinary incontinence, vaginal stenosis and
fistula between the urethra and the vagina. Fortunately, these
complications occur infrequently.
References:
1- Ludwikowski BM, Gonzalez R: The Surgical Correction of Urogenital
Sinus in Patients with DSD: 15 Years after Description of Total
Urogenital Mobilization in Children. Front Pediatr. 1:41, 2013
2- Thomas DFM: The embryology of persistent cloaca and urogenital sinus malformations. Asian Journal of Andrology 21:1-5, 2019
3- Jesus VM, Buriti F, Lessa R, Toralles MB, Oliveira LB, Barroso U Jr:
Total urogenital sinus mobilization for ambiguous genitalia. J Pediatr
Surg. 53(4):808-812, 2018
4-Birraux J, Mouafo FT, Dahoun S, Tardy V, Morel Y, Mouriquand P, Le
Coultre C, Mure PY: Laparoscopic-assisted vaginal pull-through: A new
approach for congenital adrenal hyperplasia patients with high
urogenital sinus. Afr J Paediatr Surg. 12(3):177-80, 2015
5- Leite MT, Fachin CG, de Albuquerque Maranhao RF, Shida ME, Martins
JL: Anterior sagittal approach without splitting the rectal wall.
Int J Surg Case Rep. 4(8):723-6, 2013
6- Rink RC, Cain MP: Urogenital mobilization for urogenital sinus repair. BJU Int. 102(9):1182-97, 2008
7- Hamza AF, Soliman HA, Abdel Hay SA, Kabesh AA, Elbehery MM: Total
urogenital sinus mobilization in the repair of cloacal anomalies and
congenital adrenal hyperplasia. J Pediatr Surg. 36(11):1656-8, 2001
PSU Volume 53 No 05 NOVEMBER 2019
Intercostal Cryoanalgesia
Intercostal cryoanalgesia refers to the localized freezing
of intercostal peripheral nerve through the application of a cryoprobe
which achieves freezing temperatures. Intercostal cryoanalgesia
achieved by application of a cryoprobe at -60 degree C for two minutes
to the intercostal nerve to induce axonotmesis. When the intercostal
nerve axon is frozen, the transmission of an electrical signal along
the axon is prevented providing analgesia to that dermatome. Thereafter
Wallerian degeneration of axons occurs starting at the point of injury
and moving toward the nerve endings. Axonal regeneration eventually
occurs since the fibrous neural structures including the perineurium
and epineurium are preserved. Axonal regeneration occurs at a rate of
one to 3 mm/day. This regeneration process is completed in
approximately 4-6 weeks after freezing injury. Intercostal
cryoanalgesia has been utilized for the acute and chronic control of
pain after thoracotomy. In children intercostal cryoanalgesia is used
during bar placement for the Nuss procedure of pectus excavatum
deformities. The greatest advantage of using peripheral nerve freezing
for pain control during the Nuss procedure is the long period of
analgesia provided to the child. Cryoanalgesia provides pain control
for a maximum of two months until axonal regeneration occurs. The
clinical experience to date demonstrates a significant reduction in
length of hospital stay and decrease postoperative opioid requirements
in pectus excavatum patients managed with intercostal cryoanalgesia
when compared to thoracic epidurals. Transient post-cryoanalgesia
intercostal neuralgia is reported to occur in up to 20% of patients and
may be the result of an incomplete cold temperature axonal injury. A
minority of patients does complain about persistent paresthesia long
term. Ultrasound-guided percutaneous intercostal analgesia for
mastectomy has also demonstrated a potential benefit of long-term pain
control for patients.
References:
1- Sepsas E, Misthos P, Anagnostopulu M, Toparlaki O, Voyagis G,
Kakaris S: The role of intercostal cryoanalgesia in post-thoracotomy
analgesia. Interact Cardiovasc Thorac Surg. 16(6):814-8, 2013
2- Sancheti M: Freeze the pain away: The role of cryoanalgesia during a
Nuss procedure. J Thorac Cardiovasc Surg. 151(3):889-890, 2016
3- Kim S, Idowu O, Palmer B, Lee SH: Use of transthoracic cryoanalgesia
during the Nuss procedure. J Thorac Cardiovasc Surg. 151(3):887-888,
2016
4- Graves C, Idowu O, Lee S, Padilla B, Kim S: Intraoperative
cryoanalgesia for managing pain after the Nuss procedure. J Pediatr
Surg. 52(6):920-924, 2017
5- Graves CE, Moyer J, Zobel MJ, Mora R, Smith D, O'Day M, Padilla BE:
Intraoperative intercostal nerve cryoablation during the Nuss procedure
reduces length of stay and opioid requirement: A randomized clinical
trial. J Pediatr Surg. 2019 Mar 17. pii: S0022-3468(19)30204-0.
doi:10.1016/j.jpedsurg.2019.02.057.
6- Gabriel RA, Finneran JJ, Swisher MW, Said ET, Sztain JF, Khatibi B,
Wallace AM, Hosseini A, Trescot AM, Ilfeld BM: Ultrasound-guided
percutaneous intercostal cryoanalgesia for multiple weeks of analgesia
following mastectomy: a case series. Korean J Anesthesiol. 2019 Sep 2.
doi: 10.4097/kja.19332.
Bronchopleural Fistula
Bronchopleural fistula (BPF) is a sinus tract communication
between the main stem, lobar or segmental bronchus and the pleural
space. BPF is considered a serious complication after pneumonectomy or
any other pulmonary resection. Other common causes of BPF include after
pulmonary infection causing necrosis, persistent spontaneous
pneumothorax, chemotherapy or radiotherapy from malignancy or
tuberculosis. BPF are classified as early if it develops during the
first seven days after the insult, intermediate if they occur between
eight and 30 days and late if they present after 30 days. The list of
causes of BPF is numerous but most cases occur after lung resection
(pneumonectomy, lobectomy or segmentectomy). Postoperative BPF is
classified as acute, subacute or chronic. Symptoms can include tension
pneumothorax, asphyxiation, dyspnea, hypotension, subcutaneous
emphysema, cough with expectoration, tracheal or mediastinal shift,
persistent air leak and a reduction in pleural effusions in chest
films. Chronic cases develop more insidious symptoms such as failure to
thrive, malaise and fever. If a BPF occurs early in the postop period
it is usually caused by mechanical failure of bronchial stump closure
and requires urgent surgery as symptoms can be catastrophic. Most
children with BPF present symptoms in the first two weeks after lung
resection. Diagnosis of BPF is made using clinical, radiographic and
bronchoscopic findings that confirm air leak from a bronchus to the
pleural space. CT Scan can reveal the fistulous tract between the
bronchus and pleura. Initial management of BPF is chest tube drainage
of air and fluid from the pleural cavity. Suture closure of the opened
bronchial stump using a vascularized flap coverage with video-assisted
thoracoscopic approach is curative for the BPF presenting in the first
two weeks. Other times the BPF can be closed using a muscle flap to
fill the pleural space through a formal thoracotomy. Children with
mechanical ventilation have a more complicated disease course due to
the persistent air leak and incomplete lung expansion. BPF cause
significant morbidity, prolonged hospitalization and
mortality.
References:
1- Giubergia V, Alessandrini F, Barrias C, Giuseppucci C, Reusmann A,
Barrenechea M, Castaros C: Risk factors for morbidities and mortality
in children following pneumonectomy. Respirology. 22(1):187-191, 2017
2- Pandian TK, Aho JM, Ubl DS, Moir CR, Ishitani MB, Habermann EB: The
rising incidence of pediatric empyema with fistula. Pediatr Surg Int.
32(3):215-20, 2016
3- Goussard P, Gie R, Andronikou S, Morrison JL: Organic foreign body
causing lung collapse and bronchopleural fistula with empyema. BMJ Case
Rep. 2014 Apr 4;2014. pii: bcr2014204633. doi: 10.1136/bcr-2014-204633
4- Jester I, Nijran A, Singh M, Parikh DH: Surgical management of
bronchopleural fistula in pediatric empyema and necrotizing pneumonia:
efficacy of the serratus anterior muscle digitation flap. J Pediatr
Surg. 47(7):1358-62, 2012
5- Deschamps C, Bernard A, Nichols FC 3rd, Allen MS, Miller DL, Trastek
VF, Jenkins GD, Pairolero PC: Empyema and bronchopleural fistula after
pneumonectomy: factors affecting incidence. Ann Thorac Surg.
72(1):243-7, 2001
6- Keckler SJ, Spilde TL, St Peter SD, Tsao K, Ostlie DJ: Treatment of
bronchopleural fistula with small intestinal mucosa and fibrin glue
sealant. Ann Thorac Surg. 84(4):1383-6, 2007
Appendiceal Stump Bleeding
Lower gastrointestinal bleeding arising from the appendix is
an extremely rare condition. Several pathologic conditions have been
reported to be related to bleeding from the appendix such as Crohn's
disease, appendicitis, intussusception, angiodysplasia, neoplasm,
endometriosis, erosion of the appendiceal mucosa and stump granuloma.
The use of CT-Scan in conjunction with colonoscopy may aid in making an
accurate diagnosis with regard to appendiceal bleeding.
Gastrointestinal bleeding from the appendiceal stump after appendectomy
is also extremely rare. The bleeding may drain into the peritoneal
cavity, the retroperitoneum or into the lumen of the bowel presenting
as hematochezia or melena. The cause of the bleeding is usually a small
intramural branch of the appendiceal artery at the appendiceal stump.
Appendiceal bleeding may be managed by endoscopic clipping, arterial
embolization or surgical cecal resection if massive. Granulomatous
appendicitis characterized by appendicular granulomas can also present
with lower gastrointestinal bleeding. Granulomas are chronic
inflammatory lesions consisting of clusters of epithelioid histiocytes
accompanied by multinucleated giant cells and lymphocytes. This
condition accounts for less than 2% of all appendicitis and only 5010%
of them develop Crohn's disease. Subacute appendicitis produces
granulomatous reaction in relation to a secondary inflammatory response
to acute appendicitis or phlegmonous process managed conservatively
with postponed appendectomy. The definitive management of granulomatous
appendicitis is appendectomy with a good long term prognosis.
Appendiceal stump granuloma bleeding can be managed expectantly since
as soon as the inflammatory process subsides the bleeding will
stop.
References:
1- Chiang CC, Tu CW, Liao CS, Shieh MC, Sung TC: Appendiceal hemorrhage
- An uncommon cause of lower gastrointestinal bleeding. Journal of the
Chinese Medical Association 74 (6): 277-279, 2011
2- Simsek Z, Karaahmet F, Yuksel O, Yilmaz B, Coban S: Successful
endoscopic treatment of massive bleeding related to the appendiceal
stump. Endoscopy. 2013;45 Suppl 2 UCTN:E15. doi:
10.1055/s-0032-1326115. Epub 2013 Mar 6.
3- Wani HU, Omosola AO, Shadi S, Mahmoud, Butt MT, Al Kaabi SR:
Endoscopic treatment of massive lower gastrointestinal bleeding related
to appendiceal stump. Endoscopy. 47: E225-E226, 2015
4- Magaz Martinez M, Martin Lopez J, De la Revilla Negro J, et al:
Appendicular bleeding: an excepcional cause of lower hemorrhage. Rev
Esp Enferm Dig. 108(7):437-9, 2016
5- Pantanowitz L: Appendiceal granulation polyp. Int J Surg Pathol. 16(4):428-9, 2008
6- Baek SK, Kim YH, Kim SP: Acute lower gastrointestinal bleeding due
to appendiceal mucosal erosion. Surg Laparosc Endosc Percutan Tech.
20(3):e110-3, 2010
PSU Volume 53 NO 06 DECEMBER 2019
Choledocholithiasis in Sickle Cell Disease
Sickle cell disease (SCD) is a vaso-occlusive hemolytic
anemia that causes pigmented gallbladder and common bile duct stones
(choledocholithiasis) due to increase red blood cell destruction.
Elevated serum bilirubin is produced from the breakdown of heme release
from hemolyzed erythrocytes. Choledocholithiasis can occur
concomitantly with gallstones (secondary) or years after removal of the
gallbladder (primary). Most cases (95%) of bile ducts stones in SCD are
from migration of gallstones from the gallbladder. Diagnosis of primary
common bile duct stones depends on the following criteria: 1) previous
removal of the gallbladder with or without bile duct exploration, 2) at
least two year asymptomatic period after surgery and 3) no evidence of
biliary stricture from surgery. Once cholelithiasis is diagnosed
cholecystectomy in children with SCD should be performed to avoid the
morbidity associated such as cholecystitis, biliary colic,
pancreatitis, bile duct obstruction and cholangitis. The SCD child with
gallstones and bile duct obstruction, bile duct dilatation in US,
pancreatitis, elevated total bilirubin and alkaline phosphatase or
cholangitis should undergo an MRCP to rule out choledocholithiasis. If
bile duct stones are diagnosed then an ERCP with sphincterotomy and
stone extraction is the next step in management. The advantage of the
preoperative ERCP is that the bile ducts obstruction is cleared
reducing chance of biliary infection. This is then followed by
laparoscopic cholecystectomy. Should ERCP fails to clear the
common bile duct of stones and the obstruction persists laparoscopic
cholecystectomy with exploration of the bile duct and stone retrieval
is in order. Recurrent biliary tract disease is a frequent complication
of SCD (20% by age 4 years) and often presents as common bile duct
obstruction by stone despite cholecystectomy. Increased perioperative
complications may result from vaso-occlusion after transient hypoxia,
hypothermia, dehydration and acidosis. Inadequate postoperative pain
management may reduce respirator effort leading to poor pulmonary
toilet, hypoxia and acute chest syndrome from intrapulmonary
vaso-occlusive crisis.
References:
1- Sandoval C, Stringel G, Ozkaynak MF, Tugal O, Jayabose S:
Perioperative management in children with sickle cell disease
undergoing laparoscopic surgery. JSLS. 6(1):29-33, 2002
2- Vicari P, Gil MV, Cavalheiro Rde C, Figueiredo MS: Multiple primary
choledocholithiasis in sickle cell disease. Intern Med. 47(24):2169-70,
2008
3- Ingle SS, Ubale P: Anesthetic management of a patient with sickle
cell disease for common bile duct exploration. J Anaesthesiol Clin
Pharmacol. 27(4): 547-549, 2011
4- Issa H, Al-Salem AH: Role of ERCP in the era of laparoscopic
cholecystectomy for the evaluation of choledocholithiasis in sickle
cell anemia. World J Gastroenterol. 17(14):1844-7, 2011
5- Al-Salem AH, Issa H: Laparoscopic cholecystectomy in children with
sickle cell anemia and the role of ERCP. Surg Laparosc Endosc Percutan
Tech. 22(2):139-42, 2012
6- Amoako MO, Casella JF, Strouse JJ: High rates of recurrent biliary
tract obstruction in children with sickle cell disease. Pediatr Blood
Cancer. 60(4):650-2, 2013
Congenital Uterovaginal Prolapse
Uterovaginal prolapse (UVP) occurring in the neonatal period
is very rare. Uterovaginal prolapse refers to the downward descent with
protrusion of the uterus and vagina to the exterior through the
introitus. Uterovaginal prolapse occurs due to weakness of the cardinal
ligaments and uterosacral ligaments that provide support to the uterus
and vagina. Most cases are associated with congenital anomalies of the
spine such as spina bifida occulta or myelomeningocele due to
maldevelopment of sacral innervation to the levator ani muscle
(perineal branch of the sacral nerve). Congenital UVP is also seen in
babies with congenital cutis laxa. Congenital UVP manifest symptoms at
birth or within the first few days of life. A few cases are caused by
abnormal stress such as prolonged labor in breach condition, birth
trauma or abnormality of the cervix. Diagnosis is clinical: pink-fleshy
mass is seen protruding from the introitus with circumferential
prolapse of the vaginal wall. The external cervical os is usually seen
at the upper end of the lesion with a normal appearing urethral
orifice. Differential diagnosis includes vaginal polyp, urethral
prolapse, paraurethral cysts and rhabdomyosarcoma botryoides. CT or MRI
is diagnostic and helps clear the differential diagnosis. Management of
congenital uterovaginal prolapse is conservative with single or
repeated manual reduction of the defect. Hypertonic saline packs or
vaginal pessaries have also been utilized. As genital edema subsides
the prolapse is usually maintained in place. Surgical intervention is
indicated when conservative management fails, when the prolapse becomes
recurrent after repeated reductions or when there is evidence of
vaginal mucosal hypertrophy or ulceration. These include fixation of
the uterus anteriorly to the urinary bladder with nonabsorbable sutures
using a small suprapubic incision, sling or sacral cervicopexy.
Inflated Foley catheter into the vaginal orifice after reduction for a
period of two weeks can also successfully correct the uterovaginal
prolapse.
References:
1- Abdelsalam SE, Desouki NM, Abd alaal NA: Use of Foley catheter for
management of neonatal genital prolapse: case report and review of the
literature. J Pediatr Surg. 41(2):449-52, 2006
2- Hyginus EO, John CO: Congenital uterovaginal prolapse present at birth. J Surg Tech Case Rep. 5(2):89-91, 2013
3- Jijo ZW, Betele MT, Ali AS: Congenital Uterovaginal Prolapse in a
Newborn. Case Rep Obstet Gynecol. 2018 Jun 27;2018:1425953. doi:
10.1155/2018/1425953. eCollection 2018.
4- Saha DK, Hasan KM, Rahman SM, Majumder SK, Zahid MK, Chakraborty AK,
Bari MS: Neonatal uterine prolapse - a case report. Mymensingh Med J.
23(2):401-5, 2014
5- Choudhary SV, Bisati S, Koley S: Congenital cutis laxa with rectal
and uterovaginal prolapse. Indian J Dermatol Venereol Leprol.
77(3):321-4, 2011
6- Taksande AM, Vilhekar KY, Batra P, Jain M: Neonatal genital prolapse. J Indian Med Assoc. 109(7):502-3, 2011
Cushing's Syndrome
Cushing syndrome refers to the constellation of signs and
symptoms associated with excessive production of cortisol. Cushing
syndrome (CS) is caused by an ACTH producing pituitary or ectopic tumor
(ACTH-dependent) or an adrenal adenoma/carcinoma (ACTH-independent).
The child with CS develops hypertension, diabetes mellitus,
hypokalemia, alkalosis, bone loss, fractures and psychiatric
disturbances. CS patients suffer from infection, myocardial infarction
or venous thrombosis. The primary source of ACTH should be eliminated
as two-thirds of deaths are related to CS cortisol excess. Effective
management includes normalization of cortisol levels or inhibiting its
receptor to eliminate signs and symptoms of CS even if there is no
established diagnosis. It also includes normalizing comorbidities using
adjunctive therapy. Medical therapy with steroidogenesis inhibitors
(metyrapone and ketoconazole) can reduce plasma cortisol levels.
It is recommended that initial resection of primary lesions underlying
Cushing disease, ectopic and adrenal etiology be performed to reduce
glucocorticoid excess. These include resecting unilateral adrenal
disease, ectopic ACTH-secreting tumors with node dissection,
transsphenoidal selective removal of pituitary tumors and surgical
resection of bilateral adrenal disorders. Most cases (90%) of pediatric
CS are due to pituitary adenomas and they are primarily managed with
trans-sphenoidal surgery. ACTH-independent causes of CS in children are
less than 10% and comprises adrenal cortex adenomas or hyperplasia.
Laparoscopic surgical resection of disease adrenal gland whether
unilateral or bilateral is highly and rapidly effective in eliminating
the source of cortisol. Infantile ACTH-independent CS is very rare and
usually reported as part of Mc-Cune Albright (large adrenal glands due
to macro-nodular hyperplasia) or Carney complex disease (pigmented
nodular hyperplasia). Failed pituitary management of CS or selected
patients with ACTH-dependent CS from unmanageable primary source with
reasonable life expectancy may benefit from medical therapy with
inhibitors plus bilateral removal of the adrenal glands for control of
symptoms.
References:
1- Morris LF, Harris RS, Milton DR, et al: Impact and timing of
bilateral adrenalectomy for refractory adrenocorticotropic
hormone-dependent Cushing's syndrome. Surgery. 154(6):1174-83, 2013
2- Nieman LK, Biller BM, Findling JW, et al: Treatment of Cushing's
Syndrome: An Endocrine Society Clinical Practice Guideline. J Clin
Endocrinol Metab. 100(8):2807-31, 2015
3- Paduraru DN, Nica A, Carsote M, Valea A: Adrenalectomy for Cushing's
syndrome: do's and don'ts. J Med Life. 9(4):334-341, 2016
4- Simforoosh N, Razzaghy Azar M, Soltani MH, Nourbakhsh M, Shemshaki
H: Staged Bilateral Laparoscopic Adrenalectomy for Infantile
ACTH-independent Cushing's Syndrome (Bilateral Micronodular
Non-pigmented Adrenal Hyperplasia): A Case Report. Urol J.
14(5):5030-5033, 2017
5- Maccora D, Walls GV, Sadler GP, Mihai R: Bilateral adrenalectomy: a
review of 10 years' experience. Ann R Coll Surg Engl. 99(2):119-122,
2017
6- Al-Otaibi KM, Abduljabbar MA: Symptomatic cycling Cushing disease
managed by simultaneous bilateral laparoscopic adrenalectomy in a
11-year-old boy. J Family Community Med. 21(1):61-4, 2014